High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases-One with a remarkable thoracic response as well

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)102-105
JournalLung Cancer
Volume80
Issue number1
DOIs
Publication statusPublished - 2013

Cite this